TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying SEGRO plc
issuer of existing shares to which voting
rights are attached: ii
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which
may result in the acquisition of shares already issued to which voting
rights are attached
An acquisition or disposal of instruments with similar economic effect
to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please Following the sale of part of the AXA Life X
specify): Insurance business to Resolution PLC, changes have
been made to the direct and indirect holdings.
3. Full name of person(s) subject to AXA S.A., 25, Avenue Matignon, 75008
the notification obligation: iii Paris and its group of companies.
4. Full name of shareholder(s) (if
different from 3.):iv
5. Date of the transaction and date 15/09/2010
on which the threshold is crossed or
reached: v
6. Date on which issuer notified: 20/09/2010
7. Threshold(s) that is/are crossed 3%
or reached: vi, vii
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of Situation previous Resulting situation after
shares to the triggering the triggering
transaction transaction
if possible Number Number Number Number of % of voting
using of of of voting rights x
the ISIN CODE Shares Voting shares rights
Rights
Direct Direct Indirect Direct Indirect
xi xii
GB00B5ZN1N88 28,211,269 28,211,269 922,414 922,414 27,342,945 0.12 3.69
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date xiii Conversion Period rights that may be rights
xiv acquired if the
instrument is
exercised/
converted.
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments xv, xvi
Resulting situation after the triggering transaction
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date xvii Conversion rights instrument rights xix, xx
instrument period refers to
xviii
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
28,265,359 3.81%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Name of the Company / Number of Shares % of issued share capital
Fund
AXA Australia 196,262 0.026467
Indirect
AXA Colonia Konzern 14,000 0.001888
Direct
AXA Financial, Inc 126,364 0.017041
Indirect
AXA France 2,951,112 0.397976
Indirect
AXA IM UK 908,414 0.122505
Direct
AXA IM UK 24,025,931 3.240049
Indirect
AXA Rosenberg 43,276 0.005836
Indirect
Total Direct 922,414 0.12439
Total Indirect 27,342,945 3.68737
Total 28,265,359 3.81176
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy
holder will cease to hold:
12. Date on which proxy holder will
cease to hold voting rights:
13. Additional information:
14. Contact name: Harriet Huband
15. Contact telephone number: 020 7451 9083
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.